Search in:

Biotechnology & Biotechnological Equipment Volume 29, 2015 - Issue 1

Submit an article Journal homepage

Open access

784

Views

CrossRef citations to date

Altmetric

Article; Medical Biotechnology

Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease

Ruixia MaDepartment of Nephrology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong, P.R. ChinaCorrespondence[email protected]
View further author information

Yan XuDepartment of Nephrology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information

Wei JiangDepartment of Nephrology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information

Wei ZhangDepartment of Nephrology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information

Pages 139-146 | Received 28 Feb 2014, Accepted 05 Aug 2014, Published online: 11 Dec 2014

Cite this article
https://doi.org/10.1080/13102818.2014.989727
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Hongyun Wang, Hongyan Liu, Xue Xue, Qiong Wang & Jun Yuan. (2023) Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis. Frontiers in Pharmacology 14.
Crossref

Jing Zhang, Si-lan Li, Wen Lin, Rong-hua Pan, Yue Dai & Yu-feng Xia. (2022) Tripterygium glycoside tablet attenuates renal function impairment in diabetic nephropathy mice by regulating triglyceride metabolism. Journal of Pharmaceutical and Biomedical Analysis 221, pages 115028.
Crossref

Dandan Xie, Kai Li, Tianpeng Ma, Huan Jiang, Fei Wang, Mingyue Huang, Zhifeng Sheng & Yiqiang Xie. (2022) Therapeutic Effect and Safety of Tripterygium Glycosides Combined With Western Medicine on Type 2 Diabetic Kidney Disease: A Meta-Analysis. Clinical Therapeutics 44:2, pages 246-256.e10.
Crossref

Muhammad Ali Khan, Andrew J Kassianos, Wendy E Hoy, AHM Khurshid Alam, Helen G Healy & Glenda C Gobe. (2022) Promoting Plant-Based Therapies for Chronic Kidney Disease. Journal of Evidence-Based Integrative Medicine 27, pages 2515690X2210796.
Crossref

Hua-Bin Guo, Jia-Qing Peng, Xuan Wang, Ke-Kai Zhang, Guang-Zhi Zhong, Wei-Hong Chen & Gui-Xin Shi. (2021) Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials. BMC Nephrology 22:1.
Crossref

Nur Samsu. (2021) Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International 2021, pages 1-17.
Crossref

Wei-jun Huang, Wei-jing Liu, Yong-hua Xiao, Hui-juan Zheng, Yao Xiao, Qi Jia, Han-xue Jiang, Ze-bing Zhu, Chen-hui Xia, Xue-ting Han, Rui-xi Sun, He Nan, Zheng-dong Feng, Shi-dong Wang & Jin-xi Zhao. (2020) Tripterygium and its extracts for diabetic nephropathy: Efficacy and pharmacological mechanisms. Biomedicine & Pharmacotherapy 121, pages 109599.
Crossref

Dan Luo, Zhengyun Zuo, Hongyan Zhao, Yong Tan & Cheng Xiao. (2019) Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice. Frontiers of Medicine 13:5, pages 556-563.
Crossref

Yumin Wen, Meihua Yan, Bingxuan Zhang & Ping Li. (2017) Chinese medicine for diabetic kidney disease in China. Nephrology 22, pages 50-55.
Crossref

Wei Wu, Jing-Jing Yang, Hai-Ming Yang, Meng-Meng Huang, Qi-Jun Fang, Ge Shi, Zhi-Min Mao, Wen-Bei Han, Shan-Mei Shen & Yi-Gang Wan. (2017) Multi-glycoside of Tripterygium wilfordii Hook. f. attenuates glomerulosclerosis in a rat model of diabetic nephropathy by exerting anti-microinflammatory effects without affecting hyperglycemia. International Journal of Molecular Medicine 40:3, pages 721-730.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date